Previous 10 | Next 10 |
2023-08-18 13:14:27 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of biotechnology firm Aditxt (NASDAQ: ADTX ) — which specializes in therapeutics and technologies that monitor and modulate the immune system — popped up 25% on...
Aditxt, Inc. (NASDAQ: ADTX) is one of today's top gainers. The company's shares are currently up 4,621% on the day to $18.86. Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune reprogramming and monitoring. It develops Adi...
2023-08-18 10:19:27 ET Gainers: Aditxt ( ADTX ) +50% . AlloVir ( ALVR ) +18% . Agenus ( AGEN ) +7% . Veru ( VERU ) +7% . Akari Therapeutics ( AKTX ) +6% . Losers: Evelo Biosciences ( EVLO ) -37% . Diffusi...
Aditxt®, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation company focused on innovation and activation of precision medicine therapeutics and technologies that monitor and modulate the immune system, is pleased to provide an important update ...
2023-08-17 13:38:12 ET More on Aditx Therapeutics Aditxt stock rises ~10% on plans to buy 50% stake in Global Response Aid from Cellvera Aditxt dips on pricing of $20M public offering For further details see: Aditxt announces 1-for-40 reverse stock split
Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, announced today that it will effect a 1-for-40 reverse split of its common stock effective as of 9:30 a.m....
Aditxt (NASDAQ: ADTX) , a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, today announced the signing of an exclusive non-binding letter of intent (“LOI”) by its wholly owned subsidiary, Pearsanta(TM) Inc., to acquire b...
The proposed acquisition is expected to act as a catalyst for strategic revenues while strengthening Pearsanta’s operational infrastructure and product offerings. The proposed acquisition is also intended to bring additional depth to Pearsanta’s roster of top-tier scientists and exe...
2023-05-05 13:09:12 ET The simple definition of penny stocks includes stocks under $5. Some traders might say they are limited to only the Over-The-Counter or “OTC exchange.” But in reality, plenty of cheap stocks are trading on larger exchanges. In the stock market today,...
Aditxt (NASDAQ: ADTX) , a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, and its subsidiary Adimune(TM) Inc. announced a clinical trial agreement with Mayo Clinic. The clinical trial, which is designed to advance clinical studi...
News, Short Squeeze, Breakout and More Instantly...
ADiTx Therapeutics Inc. Company Name:
ADTX Stock Symbol:
NASDAQ Market:
ADiTx Therapeutics Inc. Website:
SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- Women’s health innovator Evofem Biosciences, Inc. (“Evofem” or “the Company”) (OTCQB: EVFM) today announced that Saundra Pelletier, Chief Executive Officer and Amy Raskopf, Chief Business Development Officer...
Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious disease and biodefense markets. Subject to the renewal of certain legislation, two programs are potentially eligible for FDA Priority Review Vouchers Aditxt, Inc. (...
Evofem Biosciences Inc. (OTCQB: EVFM) , a company commercializing innovative products to address unmet needs in women's sexual and reproductive health, has signed a license and supply agreement for the Middle East rights to Phexxi(R), Evofem's FDA-approved, hormone-free contra...